0001144204-19-037447.txt : 20190802 0001144204-19-037447.hdr.sgml : 20190802 20190802160243 ACCESSION NUMBER: 0001144204-19-037447 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190802 DATE AS OF CHANGE: 20190802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semler Scientific, Inc. CENTRAL INDEX KEY: 0001554859 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 261367393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36305 FILM NUMBER: 19995955 BUSINESS ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 BUSINESS PHONE: 408-627-4557 MAIL ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 10-Q 1 tv525967_10q.htm FORM 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2019

 

OR

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___ to ___

 

Commission File Number 001-36305

 

SEMLER SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 26-1367393
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)

 

911 Bern Court, Suite 110

San Jose, CA 95112

(Address of principal executive offices) (Zip Code)

 

(877) 774-4211

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large Accelerated Filer ¨   Accelerated Filer ¨
         
Non-Accelerated Filer ¨   Smaller Reporting Company x
      Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨    No x

 

As of August 1, 2019, there were 6,499,976 shares of the issuer’s common stock, $0.001 par value per share, outstanding.

 

 

 

   

 

 

TABLE OF CONTENTS

 

      Page
Part I.   Financial Information 1
       
Item 1.   Financial Statements 1
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3.   Quantitative and Qualitative Disclosures about Market Risk 15
Item 4.   Controls and Procedures 16
       
Part II.   Other Information 17
       
Item 1.   Legal Proceedings 17
Item 1A.   Risk Factors 17
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds 17
Item 3.   Defaults upon Senior Securities 17
Item 4.   Mine Safety Disclosures 17
Item 5.   Other Information 17
Item 6.   Exhibits 17
       
Signatures 18

 

 i 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This quarterly report on Form 10-Q contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

 

In some cases, you can identify forward-looking statements by terminology, such as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “believes,” “seeks,” “may,” “should,” “continue,” “could” or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this report.

 

You should read this quarterly report and the documents that we reference herein and therein and have filed as exhibits to this report, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this quarterly report is accurate as of the date of this report only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. These risks and uncertainties, along with others, are described above under the heading “Risk Factors” in our annual report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 7, 2019. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this quarterly report, and particularly our forward-looking statements, by these cautionary statements.

 

 ii 

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Semler Scientific, Inc.

Condensed Statements of Income

(In thousands of U.S. Dollars, except share and per share data)

 

   (Unaudited)   (Unaudited) 
   For the three months ended June 30   For the six months ended June 30 
   2019   2018   2019   2018 
                 
Revenues  $7,953   $5,484   $14,714   $9,947 
Operating expenses:                    
Cost of revenues   885    680    1,781    1,384 
Engineering and product development   591    489    1,160    856 
Sales and marketing   2,212    1,779    4,281    3,484 
General and administrative   1,570    1,001    2,943    1,875 
Total operating expenses   5,258    3,949    10,165    7,599 
Income from operations   2,695    1,535    4,549    2,348 
                     
Interest income (expense)   1    (9)   2    (56)
Related party interest expense   -    (72)   -    (131)
Other expense   -    (1)   (2)   (2)
Other income (expense)   1    (82)   -    (189)
Income before income taxes   2,696    1,453    4,549    2,159 
Provision for taxes   77    -    77    - 
Net income  $2,619   $1,453   $4,472    2,159 
Net income per share:                    
Basic  $0.41   $0.24   $0.70   $0.36 
Diluted  $0.32   $0.19   $0.55   $0.29 
Weighted average number of shares used in computing: basic and diluted income per share                    
Basic   6,411,606    5,982,711    6,368,905    5,953,818 
Diluted   8,086,140    7,534,846    8,128,241    7,403,498 

 

See accompanying notes to unaudited condensed financial statements.

 

 1 

 

 

Semler Scientific, Inc.

Condensed Balance Sheets

(In thousands of U.S. Dollars, except share and per share data)

 

  

(Unaudited)

June 30,

   December 31, 
   2019   2018 
         
Assets          
           
Current Assets:          
Cash  $4,182   $3,284 
Trade accounts receivable, net of allowance for doubtful accounts of $52 and $52, respectively   3,509    2,801 
Prepaid expenses and other current assets   213    153 
Total current assets   7,904    6,238 
           
Assets for lease, net   1,690    1,243 
Property and equipment, net   215    223 
Long-term deposits   15    15 
Total assets  $9,824   $7,719 
           
Liabilities and Stockholders' Equity          
           
Current liabilities:          
Accounts payable  $405   $280 
Accrued expenses   2,261    2,797 
Deferred revenue   928    435 
Total current liabilities   3,594    3,512 
           
Long-term liabilities:          
           
Deferred rent   9    11 
Total long-term liabilities   9    11 
           
Stockholders' equity:          
Common stock, $0.001 par value; 50,000,000 shares authorized; 6,484,414 and 6,349,985 shares issued, and 6,459,414 and 6,324,985 outstanding (treasury shares of 25,000 and 25,000), respectively   6    6 
Additional paid-in capital   23,161    25,608 
Accumulated deficit   (16,946)   (21,418)
           
Total stockholders' equity   6,221    4,196 
           
Total liabilities and stockholders' equity  $9,824   $7,719 

 

See accompanying notes to unaudited condensed financial statements.

 

 2 

 

 

 Semler Scientific, Inc.

 Statements of Stockholders' Equity (Deficit)

 (In thousands of U.S. Dollars, except share and per share data)

 

 For the Three Months Ended June 30, 2018

 

   Common Stock   Treasury Stock             
  

Shares

Issued

  

Common

Stock

Amount

   Shares   Amount  

Additional

Paid-In

Capital

  

Accumulated

Deficit

  

Total

Stockholder's

Equity /

(Deficit)

 
Balance at March 31, 2018   5,969,834   $6    (25,000)  $-   $24,196   $(25,726)  $(1,524)
                                    
Warrant Exercises   7,800    -    -    -    -    -    - 
                                    
Stock Option Exercises   70,763    -    -    -    149    -    149 
                                    
Stock-based Compensation   -    -    -    -    138    -    138 
                                    
Net income for three months ended June 30, 2018   -    -    -    -    -    1,453    1,453 
                                    
Balance at June 30, 2018   6,048,397   $6    (25,000)  $-   $24,483   $(24,273)  $216 

 

For the Three Months Ended June 30, 2019

 

   Common Stock   Treasury Stock             
  

Shares

Issued

  

Common

Stock

Amount

   Shares   Amount  

Additional

Paid-In

Capital

  

Accumulated

Deficit

  

Total

Stockholder's

Equity /

(Deficit)

 
Balance at March 31, 2019   6,356,147   $6    (25,000)  $-   $25,719   $(19,565)  $6,160 
                                    
Warrant Re-purchase   -    -    -    -    (2,687)   -    (2,687)
                                    
Warrant Exercises   22,527    -    -    -    -    -    - 
                                    
Stock Option Exercises   105,740    -    -    -    31    -    31 
                                    
Stock-based Compensation   -    -    -    -    98    -    98 
                                    
Net income for three months ended June 30, 2019   -    -    -    -    -    2,619    2,619 
                                    
Balance at June 30, 2019   6,484,414   $6    (25,000)  $-   $23,161   $(16,946)  $6,221 

 

 For the Six Months Ended June 30, 2018 

 

   Common Stock   Treasury Stock             
  

Shares

Issued

  

Common

Stock

Amount

   Shares   Amount  

Additional

Paid-In

Capital

  

Accumulated

Deficit

  

Total

Stockholder's

Equity /

(Deficit)

 
Balance at December 31, 2017   5,902,244   $6    (25,000)  $-   $23,843   $(26,432)  $(2,583)
                                    
Warrant Exercises   40,775    -    -    -    64    -    64 
                                    
Stock Option Exercises   105,378    -    -    -    245    -    245 
                                    
Stock-based Compensation   -    -    -    -    331    -    331 
                                    
Net income for six months ended June 30, 2018   -    -    -    -    -    2,159    2,159 
                                    
Balance at June 30, 2018   6,048,397   $6    (25,000)  $-   $24,483   $(24,273)  $216 

 

 For the Six Months Ended June 30, 2019

 

   Common Stock   Treasury Stock             
  

Shares

Issued

  

Common

Stock

Amount

   Shares   Amount  

Additional

Paid-In

Capital

  

Accumulated

Deficit

  

Total

Stockholder's

Equity /

(Deficit)

 
Balance at December 31, 2018   6,349,985    6    (25,000)   -    25,608    (21,418)   4,196 
                                    
Warrant Re-purchase   -    -    -    -    (2,687)   -    (2,687)
                                    
Warrant Exercises   22,527    -    -    -    -    -    - 
                                    
Stock Option Exercises   111,902    -    -    -    44    -    44 
                                    
Stock-based Compensation   -    -    -    -    196    -    196 
                                    
Net income for six months ended June 30, 2019   -    -    -    -    -    4,472    4,472 
                                    
Balance at June 30, 2019   6,484,414   $6    (25,000)  $-   $23,161   $(16,946)  $6,221 

 

 3 

 

 

Semler Scientific, Inc.

Condensed Statements of Cash Flows

(In thousands of U.S. Dollars)

 

  

(Unaudited)

Six months ended June 30

 
   2019   2018 
     
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income  $4,472   $2,159 
           
Reconciliation of Net Income to Net Cash Provided by Operating Activities:          
Amortization of debt discount   -    16 
Accretion of non-cash interest   -    135 
Depreciation   307    249 
Loss on disposal of assets for lease   97    107 
Bad debt expense   21    20 
Stock-based compensation expense   196    331 
Changes in Operating Assets and Liabilities:          
Trade accounts receivable   (730)   (535)
Prepaid expenses and other current assets   (60)   (105)
Accounts payable   125    (303)
Accrued expenses   (538)   (570)
Deferred revenue   493    4 
Net Cash Provided by Operating Activities   4,383    1,508 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Additions to property and equipment   (63)   (105)
Purchase of assets for lease, net   (779)   (138)
Net Cash Used in Investing Activities   (842)   (243)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Re-purchase of warrants   (2,687)   - 
Exercise of warrants   -    64 
Exercise of stock options   44    245 
Payments of loans payable   -    (1,022)
Net Cash Used in Financing Activities   (2,643)   (713)
           
INCREASE IN CASH   898    552 
CASH, BEGINNING OF PERIOD   3,284    1,457 
           
CASH, END OF PERIOD  $4,182   $2,009 
Cash paid for interest  $-   $191 

 

See accompanying notes to unaudited condensed financial statements

 

 4 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

1.Basis of Presentation

 

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

 

Recently Issued Accounting Pronouncements

 

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard replaced most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing (“Topic 606”), ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $2,250 and $1,368 of revenues for the three month periods ended June 30, 2019 and 2018, respectively, and approximately $3,506 and $2,010 of revenues for the six month periods ended June 30, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

 

 5 

 

 

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“Topic 326”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU2019-04 Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326); Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

 

 6 

 

  

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.

 

2.Assets for Lease, net

 

Assets for lease consist of the following:

 

   June 30,
2019		   December 31,
2018		 
         
Assets for lease  $2,824   $2,218 
Less: accumulated depreciation   (1,134)   (975)
Assets for lease, net  $1,690   $1,243 

 

Depreciation expense amounted to $126 and $101 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $236 and $198 for the six months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $42 and $28 for the three months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $77 and $61 for the six months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $63 and $38 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $97 and $107 for the six months ended June 30, 2019 and 2018, respectively.

 

3.Property and Equipment, net

 

Capital assets consist of the following:

 

   June 30,
2019		   December 31,
2018		 
         
Capital assets  $520   $457 
Less: accumulated depreciation   (305)   (234)
Capital assets, net  $215   $223 

 

Depreciation expense amounted to $37 and $26 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $71 and $51 for the six months ended June 30, 2019 and 2018, respectively.

 

 7 

 

  

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

4.Accrued Expenses

 

Accrued expenses consist of the following:

 

   June 30,
2019		   December 31,
2018		 
         
Compensation  $1,838   $2,442 
Miscellaneous accruals   423    355 
Total accrued expenses  $2,261   $2,797 

 

5.Concentration of Credit Risk

 

Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.

 

The Company maintains cash with major financial institutions. The Company’s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.

 

Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended June 30, 2018, two customers accounted for 50.3% and 22.5% of the Company’s revenue, respectively. For the six months ended June 30, 2018, two customers accounted for 53.9% and 17.7% of the Company’s revenue, respectively. For the three months ended June 30, 2019, three customers accounted for 50.8%, 14.8% and 13.8% of the Company’s revenue, respectively. For the six months ended June 30, 2019, three customers accounted for 53.0%, 13.2% and 11.1% of the Company’s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company’s accounts receivable, respectively. As of June 30, 2019, three customers accounted for 31.4%, 30.9% and 22.8% of the Company’s accounts receivable, respectively.  The Company’s largest customer in terms of revenues for the three months ended June 30, 2019 and accounts receivable as of June 30, 2019 is a U.S. diversified healthcare company and its affiliated plans.

 

As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company’s accounts payable, respectively. As of June 30, 2019, three vendors accounted for 17.9%, 13.7%, and 10.6% of the Company’s accounts payable, respectively.

 

6.Commitments and Contingencies

 

Facilities Leases

 

The Company recognized facilities lease expenses of $17 and $18 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized facilities lease expenses of $34 and $35 for the six months ended June 30, 2019 and 2018, respectively.

 

Indemnification Obligations

 

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.

 

 8 

 

  

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

7.Warrant Repurchase – Related Party

 

On May 3, 2019, the Company entered into a Warrant Repurchase Agreement with the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which Douglas Murphy-Chutorian, M.D., the Company’s director and chief executive officer is co-Trustee with his spouse and of which he is a beneficiary. Pursuant to the warrant repurchase agreement, the Company repurchased a warrant to acquire 65,542 shares of the Company’s common stock held by the trust, which warrant had an exercise price equal to $4.50 per share and an expiration date of July 31, 2023, at an aggregate purchase price of $2,687. The purchase price reflects the difference between the aggregate exercise price of the warrant and the aggregate fair market value of the shares underlying the warrant, based on the last trade price of the Company’s common stock on May 3, 2019, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrant was cancelled and is no longer issued and outstanding.

 

8.Stock Option Plan

 

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of June 30, 2019.

 

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of June 30, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 993,200 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.

 

Aggregate intrinsic value represents the difference between the closing market value as of June 30, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the six months ended June 30, 2019 is as follows:

 

   Options Outstanding 
   Number of
Stock Options
Outstanding		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
Term (In Years)		   Aggregate
Intrinsic Value
 (in thousands)		 
Balance, January 1, 2019   1,761,447   $3.18    6.84   $55,000 
Options exercised   (117,765)   2.49           
Balance, June 30, 2019   1,643,682   $3.22    6.35   $66,528 
Exercisable as of June 30, 2019   1,478,808   $3.04    6.18   $60,129 

 

 9 

 

  

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

The total compensation cost related to unvested stock option awards not yet recognized was $598 as of June 30, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.38 years. The weighted average fair value of options granted during the six months ended June 30, 2018 was $5.97 per share, or an aggregate grant date fair value of $806. There were no options granted during the six months ended June 30, 2019.

 

On January 2, 2018, the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018, the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018, the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.

 

Determining the Fair Value of Stock Options

 

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the six months ended June 30, 2019. There were no stock options granted during the three months ended June 30, 2018. There were 135,000 stock options granted during the six months ended June 30, 2018. The following assumptions for the periods presented were:

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2019   2018   2019   2018 
Expected term (in years)                    -    -               -    5 
Risk-free interest rate   -%   -%   -%   2.02%
Expected volatility   -%   -%   -%   0.99%
Expected dividend rate   -%   -%   -%   -%

 

The assumptions are based on the following for each of the periods presented:

 

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

 

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

 

Volatility — The Company derives this number from the historical stock volatilities of the Company’s stock over a period approximately equal to the expected term of the options.

 

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

 

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

 

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

 

 10 

 

  

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

 

The Company has recorded an expense of $97 and $138 as it relates to stock-based compensation for the three months ended June 30, 2019 and 2018, respectively. The Company has recorded an expense of $196 and $331 as it relates to stock-based compensation for the six months ended June 30, 2019 and 2018, respectively:

 

   Three months ended
June 30,		   Six months ended
June 30		 
   2019   2018   2019   2018 
Cost of Revenue  $1   $1   $1   $1 
Engineering and Product Development   5    9    12    17 
Sales and Marketing   15    22    31    51 
General and Administrative   77    106    152    262 
Total  $98   $138   $196   $331 

 

9.Net Income Per Share, Basic and Diluted

 

Basic earnings per share (“EPS”) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.

 

Basic and diluted net EPS is calculated as follows:

 

   Three months ended June 30, 
   2019   2018 
   Shares   Net Income   EPS   Shares   Net Income   EPS 
Basic EPS   6,411,606   $2,619   $0.41    5,982,711   $1,453   $0.24 
Common stock warrants   168,099    -         281,224    -      
Common stock options   1,506,435    -         1,270,911    -      
Diluted EPS   8,086,140   $2,619   $0.32    7,534,846   $1,453   $0.19 

 

   Six months ended June 30, 
   2019   2018 
   Shares   Net Income   EPS   Shares   Net Income   EPS 
Basic EPS   6,368,905   $4,472   $0.70    5,953,818   $2,159   $0.36 
Common stock warrants   207,471    -         256,916    -      
Common stock options   1,551,865    -         1,195,010    -      
Diluted EPS   8,128,241   $4,472   $0.55    7,403,498   $2,159   $0.29 

 

The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net income per share for the three and six months ended June 30, 2019 and 2018 because including them would have been anti-dilutive:

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2019   2018   2019   2018 
Weighted average shares outstanding:                
Common stock warrants   -    -    -    - 
Options   -    135,000    -    135,000 
Total   -    135,000    -    135,000 

 

 11 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis should be read together with our condensed unaudited financial statements and the related notes appearing elsewhere in this quarterly report on Form 10-Q and with the audited financial statements and notes for the fiscal year ended December 31, 2018, and the information under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K filed with the SEC on March 7, 2019, or the Annual Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under “Risk Factors” in our Annual Report.

 

Overview

 

We are an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Our mission is to develop, manufacture and market innovative proprietary products and services that assist our customers in evaluating and treating chronic diseases. In 2011, we began commercializing our first patented and U.S. Food and Drug Administration, or FDA, cleared product, which measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. In March 2015, we received FDA 510(k) clearance for the next generation version of our product, QuantaFlo™, which we began commercializing in August 2015. We believe our products and services position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.

 

In the three months ended June 30, 2019, we had total revenues of $7,953,000 and net income of $2,619,000 compared to total revenues of $5,484,000 and net income of $1,453,000 in the same period in 2018. In the six months ended June 30, 2019, we had total revenues of $14,714,000 and net income of $4,472,000 compared to total revenues of $9,947,000 and net income of $2,159,000 in the same period in 2018.

 

Emerging Growth Company Elections

 

The JOBS Act provides that an emerging growth company, such as our company, can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. We have elected to avail ourselves of this exemption. As a result, our financial statements may not be comparable to other public companies that comply with public company effective dates. In the future, we may elect to opt out of the extended period for adopting new accounting standards. If we do so, we would need to disclose such decision and it would be irrevocable. We expect to cease being an emerging growth company as of December 31, 2019, the last day of the fiscal year following the fifth anniversary of our initial public offering.

 

Factors Affecting Future Results

 

We have not identified any factors that have a recurring effect that are necessary to understand period to period comparisons as appropriate, nor any one-time events that have an effect on the financials.

 

Results of Operations

 

Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018

 

Revenues

 

We had revenues of $7,953,000 for the three months ended June 30, 2019, an increase of $2,469,000, or 45%, compared to $5,484,000 in the same period in 2018. Our revenues are primarily from fees charged to customers for use of our vascular testing products and from sale of accessories used with these products. We recognized revenues of $7,647,000 from fees for our vascular testing products for the three months ended June 30, 2019, an increase of $2,279,000 compared to $5,368,000 in the same period of the prior year. The remainder was from other items, such as the sale of equipment, supplies or accessories sales, which were $306,000 in the three months ended June 30, 2019, as compared to $116,000 in the same period of the prior year.  

 

Revenues from fees for vascular testing products are recognized monthly for each unit installed with a customer, usually billed as a fixed monthly fee or as a variable monthly fee dependent on usage. The primary reason for the increase in revenues was growth in the number of installed units from both new customers and established customers, which we believe is the result of our sales and marketing efforts.

 

 12 

 

 

Operating expenses

 

We had total operating expenses of $5,258,000 for the three months ended June 30, 2019, an increase of $1,309,000, or 33%, compared to $3,949,000 in the same period in the prior year. The primary reason for this change was overall growth in our business, which led to increased compensation of the sales team, as well as an increase in our field sales and technical support personnel headcount to service the expanding number of customers. The changes in the various components of our operating expenses are described below.

 

Cost of revenues

 

We had cost of revenues of $885,000 for the three months ended June 30, 2019, an increase of $205,000, or 30%, compared to $680,000 in the same period of the prior year. The primary reason for this change was increased costs due to increased sales volume of, placement of and technical support for installations in the field. These increases were partially offset by lower depreciation per unit per month as a greater percentage of installations were software and sensor only rather than laptop, software and sensor, as well as lower residual value for retired units. As a percentage of revenues, cost of revenues decreased to 11%, as compared to 12%, primarily due to revenue growing at a faster pace than cost of revenue.

 

Engineering and product development expense

 

We had engineering and product development expense of $591,000 for the three months ended June 30, 2019, an increase of $102,000, or 21%, compared to $489,000 in the same period of the prior year. The increase was primarily due to consultant costs, personnel and other costs associated with ongoing projects related to our product development and customization efforts, including new applications for our product as well as other product enhancements.

 

Sales and marketing expense

 

We had sales and marketing expense of $2,212,000 for the three months ended June 30, 2019, an increase of $433,000, or 24%, compared to $1,779,000 in the same period of the prior year. The increase was primarily due to higher sales compensation and personnel expense, as well as increased headcount and expense, each associated with a growing business.

 

General and administrative expense

 

We had general and administrative expense of $1,570,000 for the three months ended June 30, 2019, an increase of $569,000, or 57%, compared to $1,001,000 in the same period of the prior year. The increase was primarily due to the growth in our business, which led to increased expenses to support a growing company, including higher infrastructure costs, insurance and other professional fees, as well as higher compensation and personnel expense.

 

Other income (expense)

 

We had other income of $1,000 for the three months ended June 30, 2019, an increase of $83,000, or 102%, compared to other expense of $82,000 in the same period of the prior year. The increase was primarily due to a decrease in interest expense of $81,000 associated with retirement of notes payable, and other income of $1,000.

 

Provision for income taxes

 

We had provision for income taxes of $77,000 for the three months ended June 30, 2019 compared to no provision for income taxes in the same period of the prior year, which resulted from the growth in our business and expansion into new tax jurisdictions.

 

Net income

 

For the foregoing reasons, we had net income of $2,619,000, or $0.41 per basic share and $0.32 per diluted share, for the three months ended June 30, 2019, an increase of $1,166,000, or 80%, compared to a net income of $1,453,000, or $0.24 per basic share and $0.19 per diluted share, for the same period of the prior year.

 

 13 

 

 

Six Months Ended June 30, 2019 Compared to Six Months Ended June 30, 2018

 

Revenues

 

We had revenues of $14,714,000 for the six months ended June 30, 2019, an increase of $4,767,000, or 48%, compared to $9,947,000 in the same period in 2018. Our revenues are primarily from fees charged to customers for use of our vascular testing products and from sale of accessories used with these products. We recognized revenues of $14,162,000 from fees for our vascular testing products for the six months ended June 30, 2019, an increase of $4,436,000 compared to $9,726,000 in the same period of the prior year. The remainder was from other items, such as the sale of equipment, supplies or accessories sales, which were $552,000 in the six months ended June 30, 2019, as compared to $221,000 in the same period of the prior year.

 

Revenues from fees for vascular testing products are recognized monthly for each unit installed with a customer, usually billed as a fixed monthly fee or as a variable monthly fee dependent on usage. The primary reason for the increase in revenues was growth in the number of installed units from both new customers and established customers, which we believe is the result of our sales and marketing efforts.

 

Operating expenses

 

We had total operating expenses of $10,165,000 for the six months ended June 30, 2019, an increase of $2,566,000, or 34%, compared to $7,599,000 in the same period in the prior year. The primary reason for this change was overall growth in our business, which led to increased compensation of the sales team, as well as an increase in our field sales and technical support personnel headcount to service the expanding number of customers. The changes in the various components of our operating expenses are described below.

 

Cost of revenues

 

We had cost of revenues of $1,781,000 for the six months ended June 30, 2019, an increase of $397,000, or 29%, compared to $1,384,000 in the same period of the prior year. The primary reason for this change was increased costs due to increased sales volume of, placement of and technical support for installations in the field. These increases were partially offset by lower depreciation per unit per month as a greater percentage of installations were software and sensor only rather than laptop, software and sensor, as well as lower residual value for retired units. As a percentage of revenues, cost of revenues decreased to 12%, as compared to 14%, primarily due to revenue growing at a faster pace than cost of revenue.

 

Engineering and product development expense

 

We had engineering and product development expense of $1,160,000 for the six months ended June 30, 2019, an increase of $304,000, or 36%, compared to $856,000 in the same period of the prior year. The increase was primarily due to consultant costs, personnel and other costs associated with ongoing projects related to our product development and customization efforts, including new applications for our product as well as other product enhancements.

 

Sales and marketing expense

 

We had sales and marketing expense of $4,281,000 for the six months ended June 30, 2019, an increase of $797,000, or 23%, compared to $3,484,000 in the same period of the prior year. The increase was primarily due to higher sales compensation and personnel expense, as well as increased headcount and expense, each associated with a growing business.

 

General and administrative expense

 

We had general and administrative expense of $2,943,000 for the six months ended June 30, 2019, an increase of $1,068,000, or 57%, compared to $1,875,000 in the same period of the prior year. The increase was primarily due to the growth in our business, which led to increased expenses to support a growing company, including higher infrastructure costs, insurance and other professional fees, as well as higher compensation and personnel expense.

 

Other income (expense)

 

We had no other expense for the six months ended June 30, 2019, a decrease of $189,000, or 100%, compared to $189,000 in the same period of the prior year. The decrease was primarily due to a decrease in interest expense of $187,000 associated with retirement of notes payable along with interest income of $2,000 in the current period.

 

Provision for income taxes

 

We had provision for income taxes of $77,000 for the six months ended June 30, 2019 compared to no provision for income taxes in the same period of the prior year, which resulted from the growth in our business and expansion into new tax jurisdictions.

 

 14 

 

 

Net income

 

For the foregoing reasons, we had net income of $4,472,000, or $0.70 per basic share and $0.55 per diluted share, for the six months ended June 30, 2019, an increase of $2,313,000, or 107%, compared to a net income of $2,159,000, or $0.36 per basic share and $0.29 per diluted share, for the same period of the prior year.

 

Liquidity and Capital Resources

 

We had cash of $4,182,000 at June 30, 2019 compared to $3,284,000 at December 31, 2018, and total current liabilities of $3,594,000 at June 30, 2019 compared to $3,512,000 at December 31, 2018. As of June 30, 2019, we had working capital of approximately $4,310,000. 

 

Operating activities

 

We generated $4,383,000 of net cash from operating activities for the six months ended June 30, 2019 compared to generating $1,508,000 of net cash in operating activities for the same period of the prior year. The improvement was primarily due to changes in net income, as well as both non-cash adjustments and operating assets and liabilities, which occurred due to growth in our business and affected depreciation, accrued compensation, accrued expenses, accounts payable, deferred revenue and trade accounts receivable.

 

Investing activities

 

We used $842,000 of net cash in investing activities for the six months ended June 30, 2019, which reflects purchases of assets for lease of $779,000 and fixed asset purchases of $63,000 to support our growing business.

 

We used $243,000 of net cash in investing activities for the six months ended June 30, 2018, which reflects purchases of assets for lease of $138,000 and fixed asset purchases of $105,000 to support our growing business.

 

Financing activities

 

We used $2,643,000 in net cash in financing activities during the six months ended June 30, 2019, primarily due to the re-purchase of warrants of $2,687,000 from our chief executive officer in May 2019, partially offset by proceeds from exercise of stock options of $44,000.

 

We used $713,000 in net cash in financing activities during the six months ended June 30, 2018, reflecting the payment of loans payable of $1,022,000, partially offset by proceeds from exercise of warrants and stock options of $309,000.

 

Off-Balance Sheet Arrangements

 

As of each of June 30, 2019 and December 31, 2018, we had no off-balance sheet arrangements.

 

Commitments and Contingencies

 

As of each of June 30, 2019 and December 31, 2018, other than employment/consulting agreements with key executive officers and our facilities lease obligation, we had no material commitments other than the liabilities reflected in our financial statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable.

 

 15 

 

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

In evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our chief executive officer, our senior vice president, finance and accounting and our vice president, finance, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q. Based on that evaluation, our chief executive officer, our senior vice president, finance and accounting, and our vice president, finance concluded that our disclosure controls and procedures were not effective, at the reasonable assurance level, as of the end of the period covered by this report to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (1) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to management, including our chief executive officer, senior vice president, finance and accounting, and our vice president, finance as appropriate to allow timely decisions regarding required disclosure, due to the existence of a material weakness in our internal control over financial reporting.

 

 16 

 

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during our second fiscal quarter ended June 30, 2019.

 

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Not applicable.

 

Item 1A. Risk Factors.

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

Item 6. Exhibits.

 

Exh. No.   Exhibit Name
10.1   Warrant Repurchase Agreement between Semler Scientific, Inc. and Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, dated May 3, 2019 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 7, 2019).
31.1   Rule 13a-14(a) Certification of Principal Executive Officer of Registrant
31.2   Rule 13a-14(a) Certification of Principal Financial Officer of Registrant
32.1   Section 1350 Certification
     
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema
101.CAL   XBRL Taxonomy Extension Calculation Linkbase
101.DEF   XBRL Taxonomy Extension Definition Linkbase
101.LAB   XBRL Taxonomy Extension Label Linkbase
101.PRE   XBRL Taxonomy Extension Presentation Linkbase

 

 17 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

August 2, 2019  SEMLER SCIENTIFIC, INC.
   
  By: /s/ Douglas Murphy-Chutorian, M.D.
    Douglas Murphy-Chutorian, M.D.
    Chief Executive Officer
     
  By: /s/ Andrew B. Weinstein
    Andrew B. Weinstein
    Senior Vice President, Finance and Accounting

 

 18 

 EX-31.1 2 tv525967_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Douglas Murphy-Chutorian, M.D., certify that:

 

1.           I have reviewed this quarterly report on Form 10-Q of Semler Scientific, Inc., a Delaware corporation;

 

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.           The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: August 2, 2019   
  /s/ Douglas Murphy-Chutorian, M.D.
  Douglas Murphy-Chutorian, M.D.
 

Chief Executive Officer

(Principal Executive Officer)

 

   

 

 EX-31.2 3 tv525967_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

I, Andrew B. Weinstein, certify that:

 

1.           I have reviewed this quarterly report on Form 10-Q of Semler Scientific, Inc., a Delaware corporation;

 

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.           The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: August 2, 2019   
   
  /s/ Andrew B. Weinstein
  Andrew B. Weinstein
Senior Vice President, Finance and Accounting
  (Principal Financial Officer)

 

   

 EX-32.1 4 tv525967_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

Each of the undersigned, Douglas Murphy-Chutorian, M.D., Chief Executive Officer of Semler Scientific, Inc., a Delaware corporation (the “Company”), and Andrew B. Weinstein, Senior Vice President, Finance and Accounting of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge (1) the quarterly report on Form 10-Q of the Company for the period ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Douglas Murphy-Chutorian, M.D.
  Name: Douglas Murphy-Chutorian, M.D.
  Title: Chief Executive Officer
  (Principal Executive Officer)
  Dated: August 2, 2019 
   
  /s/ Andrew B. Weinstein
  Name: Andrew B. Weinstein
  Title: Senior Vice President, Finance and Accounting
  (Principal Financial Officer)
  Dated: August 2, 2019 

 

This certification accompanies and is being “furnished” with this Report, shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

   

 

 EX-101.INS 5 smlr-20190630.xml XBRL INSTANCE DOCUMENT 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2014-09-30 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2015-01-01 2015-01-31 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2015-10-01 2015-10-31 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2016-01-01 2016-01-31 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2017-01-01 2017-01-31 0001554859 2017-12-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001554859 us-gaap:CommonStockMember 2017-12-31 0001554859 us-gaap:RetainedEarningsMember 2017-12-31 0001554859 us-gaap:TreasuryStockMember 2017-12-31 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member us-gaap:ChiefExecutiveOfficerMember 2018-01-02 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member smlr:NonEmployeeDirectorsMember 2018-01-02 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member us-gaap:ChiefExecutiveOfficerMember 2018-01-01 2018-01-02 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member smlr:NonEmployeeDirectorsMember 2018-01-01 2018-01-02 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2018-01-01 2018-01-31 0001554859 2018-01-01 2018-03-31 0001554859 2018-03-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001554859 us-gaap:CommonStockMember 2018-03-31 0001554859 us-gaap:RetainedEarningsMember 2018-03-31 0001554859 us-gaap:TreasuryStockMember 2018-03-31 0001554859 2018-04-01 2018-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001554859 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001554859 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001554859 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2018-04-01 2018-06-30 0001554859 us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2018-04-01 2018-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2018-04-01 2018-06-30 0001554859 us-gaap:WarrantMember 2018-04-01 2018-06-30 0001554859 2018-01-01 2018-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001554859 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001554859 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001554859 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2018-01-01 2018-06-30 0001554859 us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-06-30 0001554859 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001554859 2018-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001554859 us-gaap:CommonStockMember 2018-06-30 0001554859 us-gaap:RetainedEarningsMember 2018-06-30 0001554859 us-gaap:TreasuryStockMember 2018-06-30 0001554859 2018-01-01 2018-12-31 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2018-01-01 2018-12-31 0001554859 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember smlr:VendorOneMember 2018-01-01 2018-12-31 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember smlr:VendorTwoMember 2018-01-01 2018-12-31 0001554859 2018-12-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001554859 us-gaap:CommonStockMember 2018-12-31 0001554859 us-gaap:RetainedEarningsMember 2018-12-31 0001554859 us-gaap:TreasuryStockMember 2018-12-31 0001554859 2019-03-31 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001554859 us-gaap:CommonStockMember 2019-03-31 0001554859 us-gaap:RetainedEarningsMember 2019-03-31 0001554859 us-gaap:TreasuryStockMember 2019-03-31 0001554859 smlr:MurphyChutorianFamilyTrustMember smlr:WarrantRepurchaseAgreementMember 2019-05-03 0001554859 smlr:MurphyChutorianFamilyTrustMember smlr:WarrantRepurchaseAgreementMember 2019-05-01 2019-05-03 0001554859 2019-04-01 2019-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001554859 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001554859 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001554859 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2019-04-01 2019-06-30 0001554859 us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2019-04-01 2019-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2019-04-01 2019-06-30 0001554859 us-gaap:WarrantMember 2019-04-01 2019-06-30 0001554859 smlr:CustomerThreeConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001554859 2019-01-01 2019-06-30 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember smlr:VendorOneMember 2019-01-01 2019-06-30 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember smlr:VendorTwoMember 2019-01-01 2019-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001554859 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001554859 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2019-01-01 2019-06-30 0001554859 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-06-30 0001554859 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerThreeConcentrationRiskMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 smlr:CustomerThreeConcentrationRiskMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001554859 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember smlr:VendorThreeMember 2019-01-01 2019-06-30 0001554859 2019-06-30 0001554859 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001554859 us-gaap:CommonStockMember 2019-06-30 0001554859 us-gaap:RetainedEarningsMember 2019-06-30 0001554859 us-gaap:TreasuryStockMember 2019-06-30 0001554859 us-gaap:EmployeeStockOptionMember smlr:StockIncentivePlan2014Member 2019-06-30 0001554859 us-gaap:EmployeeStockOptionMember smlr:KeyPersonStockOptionPlan2007Member 2019-06-30 0001554859 2019-08-01 xbrli:shares iso4217:USD iso4217:USDxbrli:shares smlr:Customer smlr:Vendor xbrli:pure Semler Scientific, Inc. 0001554859 --12-31 Non-accelerated Filer 6499976 10-Q 2019-06-30 false 2019 Q2 true true false false Yes 5484000 9947000 7953000 14714000 680000 1384000 885000 1781000 489000 856000 591000 1160000 1779000 3484000 2212000 4281000 1001000 1875000 1570000 2943000 3949000 7599000 5258000 10165000 1535000 2348000 2695000 4549000 -9000 -56000 1000 2000 72000 131000 1000 2000 2000 -82000 -189000 1000 1453000 2159000 2696000 4549000 77000 77000 1453000 1453000 2159000 2159000 2619000 2619000 4472000 4472000 0.24 0.36 0.41 0.70 0.19 0.29 0.32 0.55 5982711 5953818 6411606 6368905 7534846 7403498 8086140 8128241 1457000 2009000 3284000 4182000 2801000 3509000 153000 213000 6238000 7904000 1243000 1690000 223000 215000 15000 15000 7719000 9824000 280000 405000 2797000 2261000 435000 928000 3512000 3594000 11000 9000 11000 9000 6000 6000 25608000 23161000 -21418000 -16946000 -2583000 23843000 6000 -26432000 0 -1524000 24196000 6000 -25726000 0 216000 24483000 6000 -24273000 0 4196000 25608000 6000 -21418000 0 6160000 25719000 6000 -19565000 0 6221000 23161000 6000 -16946000 0 7719000 9824000 52000 52000 0.001 0.001 50000000 50000000 6349985 6484414 6324985 6459414 25000 25000 5902244 -25000 5969834 -25000 6048397 -25000 6349985 -25000 6356147 -25000 6484414 -25000 2687000 2687000 2687000 2687000 64000 64000 7800 40775 22527 22527 149000 149000 245000 245000 31000 31000 44000 44000 70763 105378 105740 117765 111902 138000 138000 331000 331000 98000 98000 196000 196000 16000 135000 249000 307000 -38000 -107000 -63000 -97000 20000 21000 331000 196000 535000 730000 105000 60000 -303000 125000 -570000 -538000 4000 493000 1508000 4383000 105000 63000 138000 779000 -243000 -842000 2687000 64000 245000 44000 1022000 -713000 -2643000 552000 898000 191000 <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt; ; font-family: times new roman,times;" size="2"><b>1.</b></font></td> <td><font style="font-size: 10pt; ; font-family: times new roman,times;" size="2"><b>Basis of Presentation</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Semler Scientific, Inc., a Delaware corporation (&#8220;Semler&#8221; or &#8220;the Company&#8221;), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the &#8220;Annual Report&#8221;). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 9pt; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><b>Recently Issued Accounting Pronouncements</b></font></p> <p style="widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>Accounting Pronouncements Recently Adopted</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>&#160;</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2014-09, Revenue from Contracts with Customers (&#8220;ASU No. 2014-09&#8221;). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard replaced most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing (&#8220;Topic 606&#8221;), ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (&#8220;full retrospective method&#8221;), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (&#8220;modified retrospective method&#8221;). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Topic 606 affects revenue recognition for the Company&#8217;s variable license fee contracts, which represents approximately $2,250 and $1,368 of revenues for the three month periods ended June 30, 2019 and 2018, respectively, and approximately $3,506 and $2,010 of revenues for the six month periods ended June 30, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>Accounting Pronouncements Not Yet Adopted</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset&#8217;s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact that this new standard will have on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#8220;Topic 326&#8221;). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization&#8217;s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU2019-04 Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU 2019-05, Financial Instruments &#8211; Credit Losses (Topic 326); Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company&#8217;s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In June 2018, the FASB issued ASU No. 2018-07, Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. This standard is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.</font></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.</font></p> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>2.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Assets for Lease, net</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Assets for lease consist of the following:</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 1020px;">Assets for lease</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">2,824</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">2,218</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,134</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(975</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Assets for lease, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,690</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,243</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Depreciation expense amounted to $126 and $101 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $236 and $198 for the six months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $42 and $28 for the three months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $77 and $61 for the six months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $63 and $38 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $97 and $107 for the six months ended June 30, 2019 and 2018, respectively.</p> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>3.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Property and Equipment, net</b></font></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Capital assets consist of the following:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 1020px;">Capital assets</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">520</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">457</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(305</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(234</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Capital assets, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">215</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">223</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Depreciation expense amounted to $37 and $26 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $71 and $51 for the six months ended June 30, 2019 and 2018, respectively.</p> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>4.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Accrued Expenses</b></font></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27.35pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Accrued expenses consist of the following:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 1020px;">Compensation</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">1,838</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">2,442</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Miscellaneous accruals</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">423</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">355</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Total accrued expenses</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,261</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,797</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <div>&#160;</div> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>5.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Concentration of Credit Risk</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company maintains cash with major financial institutions. The Company&#8217;s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended June 30, 2018, two customers accounted for 50.3% and 22.5% of the Company&#8217;s revenue, respectively. For the six months ended June 30, 2018, two customers accounted for 53.9% and 17.7% of the Company&#8217;s revenue, respectively. For the three months ended June 30, 2019, three customers accounted for 50.8%, 14.8% and 13.8% of the Company&#8217;s revenue, respectively. For the six months ended June 30, 2019, three customers accounted for 53.0%, 13.2% and 11.1% of the Company&#8217;s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company&#8217;s accounts receivable, respectively. As of June 30, 2019, three customers accounted for 31.4%, 30.9% and 22.8% of the Company&#8217;s accounts receivable, respectively.<b>&#160;&#160;</b>The Company&#8217;s largest customer in terms of revenues for the three months ended June 30, 2019 and accounts receivable as of June 30, 2019 is a U.S. diversified healthcare company and its affiliated plans.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company&#8217;s accounts payable, respectively. As of June 30, 2019, three vendors accounted for 17.9%, 13.7%, and 10.6% of the Company&#8217;s accounts payable, respectively.</p> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>6.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Commitments and Contingencies</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Facilities Leases</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company recognized facilities lease expenses of $17 and $18 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized facilities lease expenses of $34 and $35 for the six months ended June 30, 2019 and 2018, respectively.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 27pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Indemnification Obligations</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company&#8217;s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company&#8217;s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.</p> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>8.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Stock Option Plan</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company&#8217;s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (&#8220;2007 Plan&#8221;) or the stockholder-approved 2014 Stock Incentive Plan (&#8220;2014 Plan&#8221;). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the &#8220;Share Reserve&#8221;), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company&#8217;s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of June 30, 2019.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of June 30, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 993,200 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.</p> <p style="text-align: center; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Aggregate intrinsic value represents the difference between the closing market value as of June 30, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company&#8217;s stock option activity and related information for the six months ended June 30, 2019 is as follows:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Options&#160;Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Number&#160;of<br />Stock Options<br />Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Exercise&#160;Price</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Remaining<br />Contractual<br />Term&#160;(In Years)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Aggregate<br />Intrinsic&#160;Value<br />&#160;(in thousands)</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 753px; font-weight: bold;">Balance, January 1, 2019</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 157px; font-weight: bold;">1,761,447</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">$</td> <td style="text-align: right; width: 157px; font-weight: bold;">3.18</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 16px; font-weight: bold;">&#160;</td> <td style="text-align: right; width: 156px; font-weight: bold;">6.84</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> <td style="width: 15px; font-weight: bold;">&#160;</td> <td style="text-align: left; width: 15px; font-weight: bold;">$</td> <td style="text-align: right; width: 156px; font-weight: bold;">55,000</td> <td style="text-align: left; width: 15px; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Options exercised</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(117,765</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.49</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="font-weight: bold;">Balance, June 30, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,643,682</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">3.22</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.35</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">66,528</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="font-weight: bold;">Exercisable as of June 30, 2019</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">1,478,808</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">3.04</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">6.18</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">60,129</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The total compensation cost related to unvested stock option awards not yet recognized was $598 as of June 30, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.38 years.&#160;<font style="color: #231f20;">The weighted average fair value of options granted during the six months ended June 30, 2018 was $5.97 per share, or an aggregate grant date fair value of $806</font>. There were no options granted during the six months ended June 30, 2019.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 19.95pt; margin: 0pt 0px 0pt 5.85pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On January 2, 2018, the Compensation Committee of the Company&#8217;s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company&#8217;s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018, the Company&#8217;s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018, the Compensation Committee of the Company&#8217;s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Determining the Fair Value of Stock Options</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the six months ended June 30, 2019. There were no stock options granted during the three months ended June 30, 2018. There were 135,000 stock options granted during the six months ended June 30, 2018. The following assumptions for the periods presented were:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Six months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 700px;">Expected term (in years)</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="text-align: right; width: 146px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="text-align: right; width: 146px;">-</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="text-align: right; width: 145px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="text-align: right; width: 145px;">5</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: justify;">Risk-free interest rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">2.02</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Expected volatility</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.99</td> <td style="text-align: left;">%</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: justify;">Expected dividend rate</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The assumptions are based on the following for each of the periods presented:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Valuation Method</i>&#160;&#8212; The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Expected Term</i>&#160;&#8212; The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the &#8220;plain-vanilla&#8221; options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Volatility</i>&#160;&#8212; The Company derives this number from the historical stock volatilities of the Company&#8217;s stock over a period approximately equal to the expected term of the options.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Risk-free Interest Rate</i>&#160;&#8212; The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Expected Dividend&#160;</i>&#8212; The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Forfeiture</i>&#160;&#8212; Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company has recorded an expense of&#160;<font style="color: #231f20;">$97 and $138&#160;</font>as it relates to stock-based compensation for the three months ended June 30, 2019 and 2018, respectively. The Company has recorded an expense of $196 and $331 as it relates to stock-based compensation for the six months ended June 30, 2019 and 2018, respectively:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="left" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months&#160;ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Six months ended<br />June 30</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 715px;">Cost of Revenue</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 149px;">1</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 149px;">1</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 149px;">1</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 148px;">1</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Engineering and Product Development</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">5</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">12</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">17</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left;">Sales and Marketing</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">15</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">22</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">31</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">51</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">General and Administrative</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">77</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">106</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">152</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">262</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">98</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">138</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">196</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">331</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <div>&#160;</div> <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>9.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Net Income Per Share, Basic and Diluted</b></font></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic earnings per share (&#8220;EPS&#8221;) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic and diluted net EPS is calculated as follows:</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,411,606</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">2,619</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.41</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,982,711</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">1,453</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.24</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">168,099</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">281,224</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,506,435</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,270,911</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,086,140</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,619</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.32</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,534,846</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,453</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.19</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,368,905</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">4,472</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.70</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,953,818</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">2,159</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.36</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">207,471</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">256,916</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,551,865</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,195,010</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,128,241</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">4,472</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.55</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,403,498</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,159</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.29</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net income per share for the three and six months ended June 30, 2019 and 2018 because including them would have been anti-dilutive:</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Six months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 1pt; width: 602px;">Options</td> <td style="padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 126px;">-</td> <td style="text-align: left; padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 126px;">135,000</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 125px;">-</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 125px;">135,000</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <div>&#160;</div> <div style="font:10pt times new roman, times, serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Semler Scientific, Inc., a Delaware corporation ("Semler" or "the Company"), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the "Annual Report"). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</div> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>Accounting Pronouncements Recently Adopted</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>&#160;</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2014-09, Revenue from Contracts with Customers (&#8220;ASU No. 2014-09&#8221;). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard replaced most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing (&#8220;Topic 606&#8221;), ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (&#8220;full retrospective method&#8221;), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (&#8220;modified retrospective method&#8221;). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Topic 606 affects revenue recognition for the Company&#8217;s variable license fee contracts, which represents approximately $2,250 and $1,368 of revenues for the three month periods ended June 30, 2019 and 2018, respectively, and approximately $3,506 and $2,010 of revenues for the six month periods ended June 30, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2"><i>Accounting Pronouncements Not Yet Adopted</i></font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset&#8217;s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact that this new standard will have on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#8220;Topic 326&#8221;). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization&#8217;s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU2019-04 Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU 2019-05, Financial Instruments &#8211; Credit Losses (Topic 326); Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company&#8217;s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 27pt; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In June 2018, the FASB issued ASU No. 2018-07, Compensation&#8212;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&#8217;s own operations by issuing share-based payment awards. This standard is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.</font></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;</font></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company&#8217;s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.</font></p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 1020px;">Assets for lease</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">2,824</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">2,218</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,134</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(975</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Assets for lease, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,690</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">1,243</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 1020px;">Capital assets</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">520</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">457</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Less: accumulated depreciation</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(305</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">(234</td> <td style="text-align: left; padding-bottom: 1pt;">)</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Capital assets, net</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">215</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">223</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,&#160;<br />2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,&#160;<br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="width: 1020px;">Compensation</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 138px;">1,838</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 137px;">2,442</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Miscellaneous accruals</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">423</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">355</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2.5pt;">Total accrued expenses</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,261</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">$</td> <td style="border-bottom: black 2.5pt double; text-align: right;">2,797</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font-family:times new roman,times,serif;font-size:10pt"><tbody><tr><td style="text-align:center;white-space:nowrap"></td><td colspan="15" style="font-weight:bold;padding-bottom:1pt;text-align:center;border-bottom:1pt solid black"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Options Outstanding</div></div></td></tr><tr style="vertical-align:bottom"><td style="text-align:center;white-space:nowrap"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Number of<br/> Stock Options<br/> Outstanding</div></div></td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Weighted<br/> Average<br/> Exercise Price</div></div></td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Term (In Years)</div></div></td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Aggregate<br/> Intrinsic Value<br/> (in thousands)</div></div></td><td style="padding-bottom:1pt;font-weight:bold"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:48%;font-weight:bold"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Balance, January 1, 2019</div></div></td><td style="width:1%;font-weight:bold"></td><td style="width:1%;font-weight:bold;text-align:left"></td><td style="width:10%;font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">1,761,447</div></div></td><td style="width:1%;font-weight:bold;text-align:left"></td><td style="width:1%;font-weight:bold"></td><td style="width:1%;font-weight:bold;text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="width:10%;font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">3.18</div></div></td><td style="width:1%;font-weight:bold;text-align:left"></td><td style="width:1%;font-weight:bold"></td><td style="width:1%;font-weight:bold;text-align:left"></td><td style="width:10%;font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">6.84</div></div></td><td style="width:1%;font-weight:bold;text-align:left"></td><td style="width:1%;font-weight:bold"></td><td style="width:6px;font-weight:bold;text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="width:80px;font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">55,000</div></div></td><td style="width:1%;font-weight:bold;text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:White"><td style="text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Options exercised</div></div></td><td></td><td style="text-align:left"></td><td style="text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">(</div></div><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">117,765</div></div></td><td style="text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">)</div></div></td><td></td><td style="text-align:left"></td><td style="text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">2.49</div></div></td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"></td><td style="text-align:left"></td><td></td><td style="text-align:left;width:6px"></td><td style="text-align:right;width:80px"></td><td style="text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font-weight:bold"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Balance, June 30, 2019</div></div></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">1,643,682</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">3.22</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">6.35</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left;width:6px"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="font-weight:bold;text-align:right;width:80px"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">66,528</div></div></td><td style="font-weight:bold;text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font-weight:bold"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">Exercisable as of June 30, 2019</div></div></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">1,478,808</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">3.04</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold;text-align:right"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">6.18</div></div></td><td style="font-weight:bold;text-align:left"></td><td style="font-weight:bold"></td><td style="font-weight:bold;text-align:left;width:6px"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">$</div></div></td><td style="font-weight:bold;text-align:right;width:80px"><div style="font-size:10pt;display:inline"><div style="font-family:Times New Roman,Times,serif;display:inline">60,129</div></div></td><td style="font-weight:bold;text-align:left"></td></tr></tbody></table> <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:93%;font:10pt times new roman, times, serif;margin:auto"><tbody><tr style="vertical-align:bottom"><td style="white-space:nowrap"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">Three months ended<br/> June 30,</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">Six months ended<br/> June 30,</td><td style="padding-bottom:1pt;font-weight:bold"></td></tr><tr style="vertical-align:bottom"><td style="white-space:nowrap"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2019</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2018</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2019</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2018</td><td style="padding-bottom:1pt;font-weight:bold"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:48%;text-align:left">Expected term (in years)</td><td style="width:1%"></td><td style="width:1%;text-align:left"></td><td style="width:10%;text-align:right"> </td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left"></td><td style="width:10%;text-align:right"> </td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left"></td><td style="width:10%;text-align:right"> </td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left"></td><td style="width:10%;text-align:right"> 5</td><td style="width:1%;text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:White"><td style="text-align:justify">Risk-free interest rate</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> 2.02</td><td style="text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="text-align:left">Expected volatility</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> 0.99</td><td style="text-align:left">%</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="text-align:justify">Expected dividend rate</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td><td></td><td style="text-align:left"></td><td style="text-align:right"> </td><td style="text-align:left">%</td></tr></tbody></table> <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt times new roman, times, serif"><tbody><tr style="vertical-align:bottom"><td style="text-align:center;white-space:nowrap"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">Three months ended<br/> June 30,</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="6" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">Six months ended<br/> June 30</td><td style="padding-bottom:1pt;font-weight:bold"></td></tr><tr style="vertical-align:bottom"><td style="text-align:center;white-space:nowrap"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2019</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2018</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2019</td><td style="padding-bottom:1pt;font-weight:bold"></td><td style="font-weight:bold;padding-bottom:1pt"></td><td colspan="2" style="font-weight:bold;text-align:center;border-bottom:Black 1pt solid;white-space:nowrap">2018</td><td style="padding-bottom:1pt;font-weight:bold"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:48%">Cost of Revenue</td><td style="width:1%"></td><td style="width:1%;text-align:left">$</td><td style="width:10%;text-align:right"> 1</td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left">$</td><td style="width:10%;text-align:right"> 1</td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left">$</td><td style="width:10%;text-align:right"> 1</td><td style="width:1%;text-align:left"></td><td style="width:1%"></td><td style="width:1%;text-align:left">$</td><td style="width:10%;text-align:right"> 1</td><td style="width:1%;text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:White"><td style="text-align:left">Engineering and Product Development</td><td></td><td style="text-align:left"></td><td style="text-align:right"> 5</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 9</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 12</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 17</td><td style="text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="text-align:left">Sales and Marketing</td><td></td><td style="text-align:left"></td><td style="text-align:right"> 15</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 22</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 31</td><td style="text-align:left"></td><td></td><td style="text-align:left"></td><td style="text-align:right"> 51</td><td style="text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:White"><td style="text-align:left;padding-bottom:1pt">General and Administrative</td><td style="padding-bottom:1pt"></td><td style="border-bottom:Black 1pt solid;text-align:left"></td><td style="border-bottom:Black 1pt solid;text-align:right"> 77</td><td style="padding-bottom:1pt;text-align:left"></td><td style="padding-bottom:1pt"></td><td style="border-bottom:Black 1pt solid;text-align:left"></td><td style="border-bottom:Black 1pt solid;text-align:right"> 106</td><td style="padding-bottom:1pt;text-align:left"></td><td style="padding-bottom:1pt"></td><td style="border-bottom:Black 1pt solid;text-align:left"></td><td style="border-bottom:Black 1pt solid;text-align:right"> 152</td><td style="padding-bottom:1pt;text-align:left"></td><td style="padding-bottom:1pt"></td><td style="border-bottom:Black 1pt solid;text-align:left"></td><td style="border-bottom:Black 1pt solid;text-align:right"> 262</td><td style="padding-bottom:1pt;text-align:left"></td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="padding-bottom:2.5pt">Total</td><td style="padding-bottom:2.5pt"></td><td style="border-bottom:Black 2.5pt double;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;text-align:right"> 98</td><td style="padding-bottom:2.5pt;text-align:left"></td><td style="padding-bottom:2.5pt"></td><td style="border-bottom:Black 2.5pt double;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;text-align:right"> 138</td><td style="padding-bottom:2.5pt;text-align:left"></td><td style="padding-bottom:2.5pt"></td><td style="border-bottom:Black 2.5pt double;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;text-align:right"> 196</td><td style="padding-bottom:2.5pt;text-align:left"></td><td style="padding-bottom:2.5pt"></td><td style="border-bottom:Black 2.5pt double;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;text-align:right"> 331</td><td style="padding-bottom:2.5pt;text-align:left"></td></tr></tbody></table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,411,606</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">2,619</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.41</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,982,711</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">1,453</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.24</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">168,099</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">281,224</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,506,435</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,270,911</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,086,140</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,619</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.32</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,534,846</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,453</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.19</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="22" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; width: 345px;">Basic EPS</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">6,368,905</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">4,472</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 157px;">0.70</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 157px;">5,953,818</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">2,159</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">0.36</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">207,471</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">256,916</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,551,865</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,195,010</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Diluted EPS</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,128,241</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">4,472</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.55</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,403,498</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,159</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.29</td> <td style="text-align: left;">&#160;</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Six months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2019</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Common stock warrants</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: #cceeff; vertical-align: bottom;"> <td style="padding-bottom: 1pt; width: 602px;">Options</td> <td style="padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 126px;">-</td> <td style="text-align: left; padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="padding-bottom: 1pt; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 13px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 126px;">135,000</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 125px;">-</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="padding-bottom: 1pt; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: left; width: 12px;">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; width: 125px;">135,000</td> <td style="text-align: left; padding-bottom: 1pt; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">-</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: left;">&#160;</td> <td style="border-bottom: black 2.5pt double; text-align: right;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td> </tr> </table> 1368000 2010000 2250000 3506000 2218000 2824000 975000 1134000 101000 198000 126000 236000 28000 61000 42000 77000 457000 520000 234000 305000 26000 51000 37000 71000 2442000 1838000 355000 423000 2 2 2 2 3 3 3 3 0.503 0.225 0.539 0.177 0.435 0.404 0.110 0.108 0.508 0.148 0.138 0.314 0.309 0.179 0.137 0.530 0.132 0.228 0.111 0.106 18000 35000 17000 34000 1761447 1643682 1478808 3.18 3.22 2.49 3.04 P6Y10M2D P6Y4M6D P6Y2M4D 55000000 66528000 60129000 P5Y 0.00 0.0202 0.00 0.00 0.00 0.0099 0.00 0.00 0.00 0.00 0.00 0.00 138000 9000 1000 106000 22000 331000 17000 1000 262000 51000 98000 5000 1000 77000 15000 196000 12000 1000 152000 31000 125000 5000 993200 0 450000 10000 2783616 407500 P10Y 188640 1500000 204943 204943 235090 0.04 0.04 0.04 0.04 0.04 598000 P1Y4M17D 5.97 806000 0.25 four - year one-year 49000 135000 281224 256916 168099 207471 1270911 1195010 1506435 1551865 1453000 2159000 2619000 4472000 0 0 0 0 0 0 0 0 1453000 2159000 2619000 4472000 135000 135000 0 135000 135000 0 0 0 0 0 0 0 <table align="center" style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="text-align: left; width: 0.5in;"><font style="font-size: 10pt;"><b>7.</b></font></td> <td style="text-align: justify;"><font style="font-size: 10pt;"><b>Warrant Repurchase &#8211; Related Party</b></font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #231f20; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 3, 2019, the Company entered into a Warrant Repurchase Agreement with the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which Douglas Murphy-Chutorian, M.D., the Company&#8217;s director and chief executive officer is co-Trustee with his spouse and of which he is a beneficiary. Pursuant to the warrant repurchase agreement, the Company repurchased a warrant to acquire 65,542 shares of the Company&#8217;s common stock held by the trust, which warrant had an exercise price equal to $4.50 per share and an expiration date of July 31, 2023, at an aggregate purchase price of $2,687. The purchase price reflects the difference between the aggregate exercise price of the warrant and the aggregate fair market value of the shares underlying the warrant, based on the last trade price of the Company&#8217;s common stock on May 3, 2019, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrant was cancelled and is no longer issued and outstanding.</p> 65542 4.50 2023-07-31 2687000 EX-101.SCH 6 smlr-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Statements of Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Assets for Lease, net link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Concentration of Credit Risk link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Warrant Repurchase - Related Party link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Stock Option Plan link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Net Income Per Share, Basic and Diluted link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Assets for Lease, net (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Stock Option Plan (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Net Income Per Share, Basic and Diluted (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Basis of Presentation (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Assets for Lease, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Property and Equipment, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Concentration of Credit Risk (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Commitments and Contingencies (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Warrant Repurchase - Related Party (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Stock Option Plan (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Net Income Per Share, Basic and Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Net Income Per Share, Basic and Diluted (Details 1) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 smlr-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 smlr-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 smlr-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 smlr-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2019
Aug. 01, 2019
Document And Entity Information [Abstract]    
Entity Registrant Name Semler Scientific, Inc.  
Entity Central Index Key 0001554859  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   6,499,976
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Current Reporting Status Yes  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Statements of Income (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues $ 7,953 $ 5,484 $ 14,714 $ 9,947
Operating expenses:        
Cost of revenues 885 680 1,781 1,384
Engineering and product development 591 489 1,160 856
Sales and marketing 2,212 1,779 4,281 3,484
General and administrative 1,570 1,001 2,943 1,875
Total operating expenses 5,258 3,949 10,165 7,599
Income from operations 2,695 1,535 4,549 2,348
Interest income (expense) 1 (9) 2 (56)
Related party interest expense   (72)   (131)
Other expense   (1) (2) (2)
Other income (expense) 1 (82)   (189)
Income before income taxes 2,696 1,453 4,549 2,159
Provision for taxes 77   77  
Net income $ 2,619 $ 1,453 $ 4,472 $ 2,159
Net income per share:        
Basic (in dollars per share) $ 0.41 $ 0.24 $ 0.70 $ 0.36
Diluted (in dollars per share) $ 0.32 $ 0.19 $ 0.55 $ 0.29
Weighted average number of shares used in computing basic and diluted income per share:        
Basic (in shares) 6,411,606 5,982,711 6,368,905 5,953,818
Diluted (in shares) 8,086,140 7,534,846 8,128,241 7,403,498
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash $ 4,182 $ 3,284
Trade accounts receivable, net of allowance for doubtful accounts of $52 and $52, respectively 3,509 2,801
Prepaid expenses and other current assets 213 153
Total current assets 7,904 6,238
Assets for lease, net 1,690 1,243
Property and equipment, net 215 223
Long-term deposits 15 15
Total assets 9,824 7,719
Current liabilities:    
Accounts payable 405 280
Accrued expenses 2,261 2,797
Deferred revenue 928 435
Total current liabilities 3,594 3,512
Long-term liabilities:    
Deferred rent 9 11
Total long-term liabilities 9 11
Stockholders' equity:    
Common stock, $0001 par value; 50,000,000 shares authorized; 6,484,414 and 6,349,985 shares issued, and 6,459,414 and 6,324,985 outstanding (treasury shares of 25,000 and 25,000), respectively 6 6
Additional paid-in capital 23,161 25,608
Accumulated deficit (16,946) (21,418)
Total stockholders' equity 6,221 4,196
Total liabilities and stockholders' equity $ 9,824 $ 7,719
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts on trade accounts receivable (in dollars) $ 52 $ 52
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 6,484,414 6,349,985
Common stock, shares outstanding 6,459,414 6,324,985
Treasury stock, shares 25,000 25,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 6 $ 0 $ 23,843 $ (26,432) $ (2,583)
Balance (in shares) at Dec. 31, 2017 5,902,244 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrant Exercises     64   64
Warrant Exercises (in shares) 40,775        
Stock Option Exercises     245   245
Stock Option Exercises (in shares) 105,378        
Stock-based Compensation     331   331
Net income       2,159 2,159
Balance at Jun. 30, 2018 $ 6 $ 0 24,483 (24,273) 216
Balance (in shares) at Jun. 30, 2018 6,048,397 (25,000)      
Balance at Mar. 31, 2018 $ 6 $ 0 24,196 (25,726) (1,524)
Balance (in shares) at Mar. 31, 2018 5,969,834 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrant Exercises (in shares) 7,800        
Stock Option Exercises     149   149
Stock Option Exercises (in shares) 70,763        
Stock-based Compensation     138   138
Net income       1,453 1,453
Balance at Jun. 30, 2018 $ 6 $ 0 24,483 (24,273) 216
Balance (in shares) at Jun. 30, 2018 6,048,397 (25,000)      
Balance at Dec. 31, 2018 $ 6 $ 0 25,608 (21,418) 4,196
Balance (in shares) at Dec. 31, 2018 6,349,985 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrant Re-purchase     (2,687)   (2,687)
Warrant Exercises (in shares) 22,527        
Stock Option Exercises     44   $ 44
Stock Option Exercises (in shares) 111,902       117,765
Stock-based Compensation     196   $ 196
Net income       4,472 4,472
Balance at Jun. 30, 2019 $ 6 $ 0 23,161 (16,946) 6,221
Balance (in shares) at Jun. 30, 2019 6,484,414 (25,000)      
Balance at Mar. 31, 2019 $ 6 $ 0 25,719 (19,565) 6,160
Balance (in shares) at Mar. 31, 2019 6,356,147 (25,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrant Re-purchase     (2,687)   (2,687)
Warrant Exercises (in shares) 22,527        
Stock Option Exercises     31   31
Stock Option Exercises (in shares) 105,740        
Stock-based Compensation     98   98
Net income       2,619 2,619
Balance at Jun. 30, 2019 $ 6 $ 0 $ 23,161 $ (16,946) $ 6,221
Balance (in shares) at Jun. 30, 2019 6,484,414 (25,000)      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 4,472 $ 2,159
Reconciliation of Net Income to Net Cash Provided by Operating Activities:    
Amortization of debt discount   16
Accretion of non-cash interest   135
Depreciation 307 249
Loss on disposal of assets for lease 97 107
Bad debt expense 21 20
Stock-based compensation expense 196 331
Changes in Operating Assets and Liabilities:    
Trade accounts receivable (730) (535)
Prepaid expenses and other current assets (60) (105)
Accounts payable 125 (303)
Accrued expenses (538) (570)
Deferred revenue 493 4
Net Cash Provided by Operating Activities 4,383 1,508
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions to property and equipment (63) (105)
Purchase of assets for lease, net (779) (138)
Net Cash Used in Investing Activities (842) (243)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Re-purchase of warrants (2,687)  
Exercise of warrants   64
Exercise of stock options 44 245
Payments of loans payable   (1,022)
Net Cash Used in Financing Activities (2,643) (713)
INCREASE IN CASH 898 552
CASH, BEGINNING OF PERIOD 3,284 1,457
CASH, END OF PERIOD $ 4,182 2,009
Cash paid for interest   $ 191
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Basis of Presentation
 6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation
1. Basis of Presentation

 

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

 

Recently Issued Accounting Pronouncements

 

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard replaced most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing (“Topic 606”), ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $2,250 and $1,368 of revenues for the three month periods ended June 30, 2019 and 2018, respectively, and approximately $3,506 and $2,010 of revenues for the six month periods ended June 30, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

  

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“Topic 326”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU2019-04 Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326); Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

  

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Assets for Lease, net
 6 Months Ended
Jun. 30, 2019
Leases, Capital [Abstract]  
Assets for Lease, net
2. Assets for Lease, net

 

Assets for lease consist of the following:

 

    June 30, 
2019		     December 31, 
2018		  
             
Assets for lease   $ 2,824     $ 2,218  
Less: accumulated depreciation     (1,134 )     (975 )
Assets for lease, net   $ 1,690     $ 1,243  

 

Depreciation expense amounted to $126 and $101 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $236 and $198 for the six months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $42 and $28 for the three months ended June 30, 2019 and 2018, respectively. Reduction to accumulated depreciation for returned items was $77 and $61 for the six months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $63 and $38 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $97 and $107 for the six months ended June 30, 2019 and 2018, respectively.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Property and Equipment, net
 6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment, net
3. Property and Equipment, net

 

Capital assets consist of the following:

 

    June 30, 
2019		     December 31, 
2018		  
             
Capital assets   $ 520     $ 457  
Less: accumulated depreciation     (305 )     (234 )
Capital assets, net   $ 215     $ 223  

 

Depreciation expense amounted to $37 and $26 for the three months ended June 30, 2019 and 2018, respectively. Depreciation expense amounted to $71 and $51 for the six months ended June 30, 2019 and 2018, respectively.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.19.2
Accrued Expenses
 6 Months Ended
Jun. 30, 2019
Accrued Liabilities, Current [Abstract]  
Accrued Expenses
4. Accrued Expenses

 

Accrued expenses consist of the following:

 

    June 30, 
2019		     December 31, 
2018		  
             
Compensation   $ 1,838     $ 2,442  
Miscellaneous accruals     423       355  
Total accrued expenses   $ 2,261     $ 2,797  
 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Concentration of Credit Risk
 6 Months Ended
Jun. 30, 2019
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk
5. Concentration of Credit Risk

 

Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.

 

The Company maintains cash with major financial institutions. The Company’s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.

 

Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended June 30, 2018, two customers accounted for 50.3% and 22.5% of the Company’s revenue, respectively. For the six months ended June 30, 2018, two customers accounted for 53.9% and 17.7% of the Company’s revenue, respectively. For the three months ended June 30, 2019, three customers accounted for 50.8%, 14.8% and 13.8% of the Company’s revenue, respectively. For the six months ended June 30, 2019, three customers accounted for 53.0%, 13.2% and 11.1% of the Company’s revenue, respectively. As of December 31, 2018, two customers accounted for 43.5% and 40.4% of the Company’s accounts receivable, respectively. As of June 30, 2019, three customers accounted for 31.4%, 30.9% and 22.8% of the Company’s accounts receivable, respectively.  The Company’s largest customer in terms of revenues for the three months ended June 30, 2019 and accounts receivable as of June 30, 2019 is a U.S. diversified healthcare company and its affiliated plans.

 

As of December 31, 2018, two vendors accounted for 11.0% and 10.8% of the Company’s accounts payable, respectively. As of June 30, 2019, three vendors accounted for 17.9%, 13.7%, and 10.6% of the Company’s accounts payable, respectively.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
6. Commitments and Contingencies

 

Facilities Leases

 

The Company recognized facilities lease expenses of $17 and $18 for the three months ended June 30, 2019 and 2018, respectively. The Company recognized facilities lease expenses of $34 and $35 for the six months ended June 30, 2019 and 2018, respectively.

 

Indemnification Obligations

 

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.19.2
Warrant Repurchase - Related Party
 6 Months Ended
Jun. 30, 2019
Warrant Repurchase Related Party abstract  
Warrant Repurchase - Related Party
7. Warrant Repurchase – Related Party

 

On May 3, 2019, the Company entered into a Warrant Repurchase Agreement with the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which Douglas Murphy-Chutorian, M.D., the Company’s director and chief executive officer is co-Trustee with his spouse and of which he is a beneficiary. Pursuant to the warrant repurchase agreement, the Company repurchased a warrant to acquire 65,542 shares of the Company’s common stock held by the trust, which warrant had an exercise price equal to $4.50 per share and an expiration date of July 31, 2023, at an aggregate purchase price of $2,687. The purchase price reflects the difference between the aggregate exercise price of the warrant and the aggregate fair market value of the shares underlying the warrant, based on the last trade price of the Company’s common stock on May 3, 2019, the date of the warrant repurchase agreement. Following the warrant repurchase, the warrant was cancelled and is no longer issued and outstanding.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan
 6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Plan
8. Stock Option Plan

 

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares as of June 30, 2019.

 

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of June 30, 2019, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 993,200 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.

 

Aggregate intrinsic value represents the difference between the closing market value as of June 30, 2019 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the six months ended June 30, 2019 is as follows:

 

    Options Outstanding  
    Number of
Stock Options
Outstanding		     Weighted
Average
Exercise Price		     Weighted
Average
Remaining
Contractual
Term (In Years)		     Aggregate
Intrinsic Value
 (in thousands)		  
Balance, January 1, 2019     1,761,447     $ 3.18       6.84     $ 55,000  
Options exercised     (117,765 )     2.49                  
Balance, June 30, 2019     1,643,682     $ 3.22       6.35     $ 66,528  
Exercisable as of June 30, 2019     1,478,808     $ 3.04       6.18     $ 60,129  

  

The total compensation cost related to unvested stock option awards not yet recognized was $598 as of June 30, 2019. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 1.38 years. The weighted average fair value of options granted during the six months ended June 30, 2018 was $5.97 per share, or an aggregate grant date fair value of $806. There were no options granted during the six months ended June 30, 2019.

 

On January 2, 2018, the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018, the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018, the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $49 during the three months ended March 31, 2018.

 

Determining the Fair Value of Stock Options

 

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. There were no stock options granted during the six months ended June 30, 2019. There were no stock options granted during the three months ended June 30, 2018. There were 135,000 stock options granted during the six months ended June 30, 2018. The following assumptions for the periods presented were:

 

    Three months ended
June 30,		     Six months ended
June 30,		  
    2019     2018     2019     2018  
Expected term (in years)                      -       -                  -       5  
Risk-free interest rate     - %     - %     - %     2.02 %
Expected volatility     - %     - %     - %     0.99 %
Expected dividend rate     - %     - %     - %     - %

 

The assumptions are based on the following for each of the periods presented:

 

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

 

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

 

Volatility — The Company derives this number from the historical stock volatilities of the Company’s stock over a period approximately equal to the expected term of the options.

 

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

 

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

 

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

 

The Company has recorded an expense of $97 and $138 as it relates to stock-based compensation for the three months ended June 30, 2019 and 2018, respectively. The Company has recorded an expense of $196 and $331 as it relates to stock-based compensation for the six months ended June 30, 2019 and 2018, respectively:

 

    Three months ended
June 30,		     Six months ended
June 30		  
    2019     2018     2019     2018  
Cost of Revenue   $ 1     $ 1     $ 1     $ 1  
Engineering and Product Development     5       9       12       17  
Sales and Marketing     15       22       31       51  
General and Administrative     77       106       152       262  
Total   $ 98     $ 138     $ 196     $ 331  
 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.19.2
Net Income Per Share, Basic and Diluted
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Net Income Per Share, Basic and Diluted
9. Net Income Per Share, Basic and Diluted

 

Basic earnings per share (“EPS”) represent net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.

 

Basic and diluted net EPS is calculated as follows:

 

    Three months ended June 30,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,411,606     $ 2,619     $ 0.41       5,982,711     $ 1,453     $ 0.24  
Common stock warrants     168,099       -               281,224       -          
Common stock options     1,506,435       -               1,270,911       -          
Diluted EPS     8,086,140     $ 2,619     $ 0.32       7,534,846     $ 1,453     $ 0.19  

 

    Six months ended June 30,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,368,905     $ 4,472     $ 0.70       5,953,818     $ 2,159     $ 0.36  
Common stock warrants     207,471       -               256,916       -          
Common stock options     1,551,865       -               1,195,010       -          
Diluted EPS     8,128,241     $ 4,472     $ 0.55       7,403,498     $ 2,159     $ 0.29  

 

The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net income per share for the three and six months ended June 30, 2019 and 2018 because including them would have been anti-dilutive:

 

    Three months ended
June 30,		     Six months ended
June 30,		  
    2019     2018     2019     2018  
Weighted average shares outstanding:                        
Common stock warrants     -       -       -       -  
Options     -       135,000       -       135,000  
Total     -       135,000       -       135,000  
 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Summary of Significant Accounting Policies and Estimates (Policies)
 6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation
Semler Scientific, Inc., a Delaware corporation ("Semler" or "the Company"), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 7, 2019 (the "Annual Report"). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.
Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU No. 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of this update provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard replaced most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU No. 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing (“Topic 606”), ASU 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption (“modified retrospective method”). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company adopted the new standard effective January 1, 2019, using the modified retrospective method. The Company determined that the adoption of this new standard did not have a material impact on its financial statements.

 

Topic 606 affects revenue recognition for the Company’s variable license fee contracts, which represents approximately $2,250 and $1,368 of revenues for the three month periods ended June 30, 2019 and 2018, respectively, and approximately $3,506 and $2,010 of revenues for the six month periods ended June 30, 2019 and 2018, respectively. Essentially all of the variable license fee contracts are with large healthcare organizations. The remainder of the revenue is earned from leasing the Company's testing product for a fixed monthly fee, which is not subject to Topic 606. It was determined that the impact of the new standard has no effect on the way revenue was currently being recognized. Reusable hardware equipment or accessories may be provided to a customer for a set price and then use of the associated software is billed to the customer monthly based on volume of use. Under this scenario, revenue is recognized when and only when the customer uses the product. The Company is rendering a service and recognizes revenue in direct proportion to how much service is rendered. The sale of the equipment or accessories is recognized as hardware sales upon shipment to the customer. The initial contract is for a specified time period with automatic renewal each period thereafter until canceled. In case there is a violation of any term of the contract, the Company may deactivate the service remotely, so that the customer cannot continue to use the product.

 

Accounting Pronouncements Not Yet Adopted

 

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU No. 2016-02"). Under the new guidance in ASU No. 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU No. 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. This ASU also provides further guidance on lessors accounting policy election to not separate non-lease components from the associated lease components and limits this to circumstances in which the non-lease component or components otherwise would be accounted for under the new revenue guidance and both (1) the timing and pattern of transfer are the same for the non-lease component(s) and associated lease component, and (2) the lease component, if accounted for separately, would be classified as a an operating lease. In December 2018, the FASB issued ASU No. 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provide narrow scope improvements for lessor accounting by permitting lessors, as an accounting policy election, to treat certain sales taxes and other similar taxes as lessee costs, to exclude lessor costs paid by lessees directly to third parties from variable payments, and clarify the accounting by lessors for variable payments that related to both a lease component and a nonlease component. In January 2019, the FASB issued ASU No. 2019-01, Leases Codification Improvements, which reinstates the exception for lessors that are not manufacturers or dealers for determining fair value of the leased property as the underlying asset’s cost, clarifies the presentation on the statement of cash flows for sales type and direct financing leases for lessors that are depository and lending institutions and clarifies the transition disclosures related to accounting changes and error corrections in the year of adoption of the ASU. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently evaluating the impact that this new standard will have on its financial statements.

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“Topic 326”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU2019-04 Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326); Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company’s fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

 

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this new standard will have a material impact on its financial statements.

  

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this ASU modify the disclosure requirements on fair value measurements removing the requirements to disclosure amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. In addition, it modified certain disclosures related to Level 3 fair value measurements and added additional disclosures regarding the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This update is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company does not anticipate this update to have a material impact on its financial statements.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.19.2
Assets for Lease, net (Tables)
 6 Months Ended
Jun. 30, 2019
Leases, Capital [Abstract]  
Schedule of assets for lease
    June 30, 
2019		     December 31, 
2018		  
             
Assets for lease   $ 2,824     $ 2,218  
Less: accumulated depreciation     (1,134 )     (975 )
Assets for lease, net   $ 1,690     $ 1,243  
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.19.2
Property and Equipment, net (Tables)
 6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment, net
    June 30, 
2019		     December 31, 
2018		  
             
Capital assets   $ 520     $ 457  
Less: accumulated depreciation     (305 )     (234 )
Capital assets, net   $ 215     $ 223  
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.19.2
Accrued Expenses (Tables)
 6 Months Ended
Jun. 30, 2019
Accrued Liabilities, Current [Abstract]  
Schedule of accrued expenses
    June 30, 
2019		     December 31, 
2018		  
             
Compensation   $ 1,838     $ 2,442  
Miscellaneous accruals     423       355  
Total accrued expenses   $ 2,261     $ 2,797  
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan (Tables)
 6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock option activity
Options Outstanding
Number of
Stock Options
Outstanding
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual
Term (In Years)
Aggregate
Intrinsic Value
(in thousands)
Balance, January 1, 2019
1,761,447
$
3.18
6.84
$
55,000
Options exercised
(
117,765
)
2.49
Balance, June 30, 2019
1,643,682
$
3.22
6.35
$
66,528
Exercisable as of June 30, 2019
1,478,808
$
3.04
6.18
$
60,129
Schedule of weighted-average Black-Scholes fair value assumptions
Three months ended
June 30,		Six months ended
June 30,
2019201820192018
Expected term (in years) 5
Risk-free interest rate % % % 2.02%
Expected volatility % % % 0.99%
Expected dividend rate % % % %
Schedule of stock-based compensation
Three months ended
June 30,		Six months ended
June 30
2019201820192018
Cost of Revenue$ 1$ 1$ 1$ 1
Engineering and Product Development 5 9 12 17
Sales and Marketing 15 22 31 51
General and Administrative 77 106 152 262
Total$ 98$ 138$ 196$ 331
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.2
Net Income Per Share, Basic and Diluted (Tables)
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Schedule of basic and diluted net EPS
    Three months ended June 30,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,411,606     $ 2,619     $ 0.41       5,982,711     $ 1,453     $ 0.24  
Common stock warrants     168,099       -               281,224       -          
Common stock options     1,506,435       -               1,270,911       -          
Diluted EPS     8,086,140     $ 2,619     $ 0.32       7,534,846     $ 1,453     $ 0.19  

 

    Six months ended June 30,  
    2019     2018  
    Shares     Net Income     EPS     Shares     Net Income     EPS  
Basic EPS     6,368,905     $ 4,472     $ 0.70       5,953,818     $ 2,159     $ 0.36  
Common stock warrants     207,471       -               256,916       -          
Common stock options     1,551,865       -               1,195,010       -          
Diluted EPS     8,128,241     $ 4,472     $ 0.55       7,403,498     $ 2,159     $ 0.29  
Schedule of weighted average shares outstanding excluded from the computation of diluted net loss per share
    Three months ended
June 30,		     Six months ended
June 30,		  
    2019     2018     2019     2018  
Weighted average shares outstanding:                        
Common stock warrants     -       -       -       -  
Options     -       135,000       -       135,000  
Total     -       135,000       -       135,000  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Basis of Presentation (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Accounting Policies [Abstract]        
Revenue recognition under variable license fee contracts $ 2,250 $ 1,368 $ 3,506 $ 2,010
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Assets for Lease, net - Summary of assets for lease (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Leases, Capital [Abstract]    
Assets for lease $ 2,824 $ 2,218
Less: accumulated depreciation (1,134) (975)
Assets for lease, net $ 1,690 $ 1,243
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.19.2
Assets for Lease, net (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Leases, Capital [Abstract]        
Depreciation expense $ 126 $ 101 $ 236 $ 198
Reduction to accumulated depreciation for returned items 42 28 77 61
Loss on disposal of assets for lease $ (63) $ (38) $ (97) $ (107)
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.19.2
Property and Equipment, net (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Property, Plant and Equipment [Abstract]    
Capital assets $ 520 $ 457
Less: accumulated depreciation (305) (234)
Capital assets, net $ 215 $ 223
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.19.2
Property and Equipment, net (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 37 $ 26 $ 71 $ 51
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Accrued Expenses - Summary of accrued expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Accrued Liabilities, Current [Abstract]    
Compensation $ 1,838 $ 2,442
Miscellaneous accruals 423 355
Total accrued expenses $ 2,261 $ 2,797
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Concentration of Credit Risk (Detail Textuals)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Customer
Jun. 30, 2018
Customer
Jun. 30, 2019
Customer
Jun. 30, 2018
Customer
Dec. 31, 2018
Customer
Vendor
Customer concentration risk | Revenue          
Concentration Risk [Line Items]          
Number of customers 3 2 3 2  
Customer concentration risk | Revenue | Customer one          
Concentration Risk [Line Items]          
Concentration risk percentage 50.80% 50.30% 53.00% 53.90%  
Customer concentration risk | Revenue | Customer two          
Concentration Risk [Line Items]          
Concentration risk percentage 14.80% 22.50% 13.20% 17.70%  
Customer concentration risk | Revenue | Customer three          
Concentration Risk [Line Items]          
Concentration risk percentage 13.80%   11.10%    
Customer concentration risk | Accounts receivable          
Concentration Risk [Line Items]          
Number of customers     3   2
Customer concentration risk | Accounts receivable | Customer one          
Concentration Risk [Line Items]          
Concentration risk percentage     31.40%   43.50%
Customer concentration risk | Accounts receivable | Customer two          
Concentration Risk [Line Items]          
Concentration risk percentage     30.90%   40.40%
Customer concentration risk | Accounts receivable | Customer three          
Concentration Risk [Line Items]          
Concentration risk percentage     22.80%    
Vendor concentration risk | Accounts payable          
Concentration Risk [Line Items]          
Number of customers     3   2
Vendor concentration risk | Accounts payable | Vendor one          
Concentration Risk [Line Items]          
Concentration risk percentage     17.90%   11.00%
Vendor concentration risk | Accounts payable | Vendor two          
Concentration Risk [Line Items]          
Concentration risk percentage     13.70%   10.80%
Vendor concentration risk | Accounts payable | Vendor three          
Concentration Risk [Line Items]          
Concentration risk percentage     10.60%    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies (Detail Textuals) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Loans Payable [Abstract]        
Facilities lease expenses $ 17 $ 18 $ 34 $ 35
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Warrant Repurchase - Related Party (Detail Textuals) - Warrant Repurchase Agreement - Murphy Chutorian Family Trust
$ / shares in Units, $ in Thousands
May 03, 2019
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Repurchase of warrant to acquire shares | shares 65,542
Warrant exercise price | $ / shares $ 4.50
Warrant expiration date Jul. 31, 2023
Warrant aggregate purchase price | $ $ 2,687
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan - Summary of stock-based compensation activity (Details)
$ / shares in Units, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Number of Stock Options Outstanding    
Balance, Beginning | shares 1,761,447  
Options exercised | shares (117,765)  
Balance, Ending | shares 1,643,682 1,761,447
Exercisable, Ending | shares 1,478,808  
Weighted Average Exercise Price    
Balance, Beginning | $ / shares $ 3.18  
Options exercised | $ / shares 2.49  
Balance, Ending | $ / shares 3.22 $ 3.18
Exercisable, Ending | $ / shares $ 3.04  
Weighted Average Remaining Contractual Term, Options Outstanding (in years) 6 years 4 months 6 days 6 years 10 months 2 days
Weighted Average Remaining Contractual Term, Options Exercisable (in years) 6 years 2 months 4 days  
Aggregate Intrinsic Value, Options Outstanding | $ $ 66,528 $ 55,000
Aggregate Intrinsic Value, Options Exercisable | $ $ 60,129  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]        
Expected term (in years)       5 years
Risk free interest rate 0.00% 0.00% 0.00% 2.02%
Expected volatility 0.00% 0.00% 0.00% 0.99%
Expected dividend rate 0.00% 0.00% 0.00% 0.00%
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan - Stock-based compensation (Details 2) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 98 $ 138 $ 196 $ 331
Cost of Revenue        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 1 1 1 1
Engineering and Product Development        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 5 9 12 17
Sales and Marketing        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 15 22 31 51
General and Administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 77 $ 106 $ 152 $ 262
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Option Plan (Detail Textuals) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Jan. 02, 2018
Jan. 31, 2018
Jan. 31, 2017
Jan. 31, 2016
Oct. 31, 2015
Jan. 31, 2015
Jun. 30, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Total unrecognized compensation cost related to non-vested stock options             $ 598     $ 598    
Weighted average period of unvested stock awards                   1 year 4 months 17 days    
Weighted average grant date fair value of options granted                     $ 5.97  
Aggregate grant date fair value                     $ 806  
One-time expense                 $ 49      
Stock-based compensation expense             $ 98 $ 138   $ 196 $ 331  
Number of stock option granted                     135,000  
2007 Key Person Stock Option Plan | Stock options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares available for future stock-based compensation grants             0     0    
Maximum number of shares issued pursuant to awards granted under plan             407,500     407,500    
2014 Stock Incentive Plan | Stock options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares available for future stock-based compensation grants             993,200     993,200    
Maximum number of shares issued pursuant to awards granted under plan             2,783,616     2,783,616   450,000
Maximum term of stock option grants         10 years              
Number of share reserve increased   235,090 204,943 204,943 1,500,000 188,640            
Percentage of shares reserve increased   4.00% 4.00% 4.00% 4.00% 4.00%            
2014 Stock Incentive Plan | Stock options | CEO                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares available for future stock-based compensation grants 125,000                      
Percentage of shares vested on one year anniversary 25.00%                      
Number of years in options fully vested four - year                      
2014 Stock Incentive Plan | Stock options | Non Employee Directors                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares available for future stock-based compensation grants 5,000                      
Maximum number of shares issued pursuant to awards granted under plan 10,000                      
Number of years in options fully vested one-year                      
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.19.2
Net Income Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Earnings Per Share [Abstract]        
Basic EPS (in shares) 6,411,606 5,982,711 6,368,905 5,953,818
Common stock warrants (in shares) 168,099 281,224 207,471 256,916
Common stock options (in shares) 1,506,435 1,270,911 1,551,865 1,195,010
Diluted EPS (in shares) 8,086,140 7,534,846 8,128,241 7,403,498
Net Income - Basic EPS $ 2,619 $ 1,453 $ 4,472 $ 2,159
Net Income - Common stock warrants 0 0 0 0
Net Income - Common stock options 0 0 0 0
Net Income - Diluted EPS $ 2,619 $ 1,453 $ 4,472 $ 2,159
Basic EPS (in dollars per share) $ 0.41 $ 0.24 $ 0.70 $ 0.36
Diluted EPS (in dollars per share) $ 0.32 $ 0.19 $ 0.55 $ 0.29
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.19.2
Net Income Per Share, Basic and Diluted (Details 1) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Weighted average shares outstanding:        
Total 0 135,000 0 135,000
Common stock warrants        
Weighted average shares outstanding:        
Total 0 0 0 0
Options        
Weighted average shares outstanding:        
Total 0 135,000 0 135,000
EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 115 224 1 false 28 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://semlerscientific.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Statements of Income (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfIncomeUnaudited Condensed Statements of Income (Unaudited) Statements 2 false false R3.htm 003 - Statement - Condensed Balance Sheets Sheet http://semlerscientific.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 3 false false R4.htm 004 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://semlerscientific.com/role/CondensedBalanceSheetsParentheticals Condensed Balance Sheets (Parentheticals) Statements 4 false false R5.htm 005 - Statement - Statements of Stockholders' Equity (Deficit) Sheet http://semlerscientific.com/role/StatementsOfStockholdersEquityDeficit Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 006 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 007 - Disclosure - Basis of Presentation Sheet http://semlerscientific.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 008 - Disclosure - Assets for Lease, net Sheet http://semlerscientific.com/role/AssetsForLeaseNet Assets for Lease, net Notes 8 false false R9.htm 009 - Disclosure - Property and Equipment, net Sheet http://semlerscientific.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 9 false false R10.htm 010 - Disclosure - Accrued Expenses Sheet http://semlerscientific.com/role/AccruedExpenses Accrued Expenses Notes 10 false false R11.htm 011 - Disclosure - Concentration of Credit Risk Sheet http://semlerscientific.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 11 false false R12.htm 012 - Disclosure - Commitments and Contingencies Sheet http://semlerscientific.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 013 - Disclosure - Warrant Repurchase - Related Party Sheet http://semlerscientific.com/role/WarrantRepurchaseRelatedParty Warrant Repurchase - Related Party Notes 13 false false R14.htm 014 - Disclosure - Stock Option Plan Sheet http://semlerscientific.com/role/StockOptionPlan Stock Option Plan Notes 14 false false R15.htm 015 - Disclosure - Net Income Per Share, Basic and Diluted Sheet http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted Net Income Per Share, Basic and Diluted Notes 15 false false R16.htm 016 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) Sheet http://semlerscientific.com/role/SummaryofSignificantAccountingPoliciesandEstimatesPolicies Summary of Significant Accounting Policies and Estimates (Policies) Policies 16 false false R17.htm 017 - Disclosure - Assets for Lease, net (Tables) Sheet http://semlerscientific.com/role/AssetsForLeaseNetTables Assets for Lease, net (Tables) Tables http://semlerscientific.com/role/AssetsForLeaseNet 17 false false R18.htm 018 - Disclosure - Property and Equipment, net (Tables) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://semlerscientific.com/role/PropertyAndEquipmentNet 18 false false R19.htm 019 - Disclosure - Accrued Expenses (Tables) Sheet http://semlerscientific.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://semlerscientific.com/role/AccruedExpenses 19 false false R20.htm 020 - Disclosure - Stock Option Plan (Tables) Sheet http://semlerscientific.com/role/StockOptionPlanTables Stock Option Plan (Tables) Tables http://semlerscientific.com/role/StockOptionPlan 20 false false R21.htm 021 - Disclosure - Net Income Per Share, Basic and Diluted (Tables) Sheet http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables Net Income Per Share, Basic and Diluted (Tables) Tables http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted 21 false false R22.htm 022 - Disclosure - Basis of Presentation (Detail Textuals) Sheet http://semlerscientific.com/role/BasisOfPresentationDetailTextuals Basis of Presentation (Detail Textuals) Details http://semlerscientific.com/role/BasisOfPresentation 22 false false R23.htm 023 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) Sheet http://semlerscientific.com/role/AssetsForLeaseNetSummaryOfAssetsForLeaseDetails Assets for Lease, net - Summary of assets for lease (Details) Details 23 false false R24.htm 024 - Disclosure - Assets for Lease, net (Detail Textuals) Sheet http://semlerscientific.com/role/AssetsForLeaseNetDetailTextuals Assets for Lease, net (Detail Textuals) Details http://semlerscientific.com/role/AssetsForLeaseNetTables 24 false false R25.htm 025 - Disclosure - Property and Equipment, net (Details) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 25 false false R26.htm 026 - Disclosure - Property and Equipment, net (Detail Textuals) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetailTextuals Property and Equipment, net (Detail Textuals) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 26 false false R27.htm 027 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) Sheet http://semlerscientific.com/role/AccruedExpensesSummaryOfAccruedExpensesDetails Accrued Expenses - Summary of accrued expenses (Details) Details 27 false false R28.htm 028 - Disclosure - Concentration of Credit Risk (Detail Textuals) Sheet http://semlerscientific.com/role/ConcentrationOfCreditRiskDetailTextuals Concentration of Credit Risk (Detail Textuals) Details http://semlerscientific.com/role/ConcentrationOfCreditRisk 28 false false R29.htm 029 - Disclosure - Commitments and Contingencies (Detail Textuals) Sheet http://semlerscientific.com/role/CommitmentsAndContingenciesDetailsTextuals Commitments and Contingencies (Detail Textuals) Details http://semlerscientific.com/role/CommitmentsAndContingencies 29 false false R30.htm 030 - Disclosure - Warrant Repurchase - Related Party (Detail Textuals) Sheet http://semlerscientific.com/role/WarrantRepurchaseRelatedPartyDetailTextuals Warrant Repurchase - Related Party (Detail Textuals) Details http://semlerscientific.com/role/WarrantRepurchaseRelatedParty 30 false false R31.htm 031 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) Sheet http://semlerscientific.com/role/StockOptionPlanSummaryOfStockBasedCompensationActivityDetails Stock Option Plan - Summary of stock-based compensation activity (Details) Details 31 false false R32.htm 032 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Sheet http://semlerscientific.com/role/StockOptionPlanWeightedAverageBlackScholesFairValueAssumptionsDetails1 Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Details 32 false false R33.htm 033 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) Sheet http://semlerscientific.com/role/StockOptionPlanStockBasedCompensationDetails2 Stock Option Plan - Stock-based compensation (Details 2) Details 33 false false R34.htm 034 - Disclosure - Stock Option Plan (Detail Textuals) Sheet http://semlerscientific.com/role/StockOptionPlanDetailTextuals Stock Option Plan (Detail Textuals) Details http://semlerscientific.com/role/StockOptionPlanTables 34 false false R35.htm 035 - Disclosure - Net Income Per Share, Basic and Diluted (Details) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails Net Income Per Share, Basic and Diluted (Details) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 35 false false R36.htm 036 - Disclosure - Net Income Per Share, Basic and Diluted (Details 1) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails1 Net Income Per Share, Basic and Diluted (Details 1) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 36 false false All Reports Book All Reports smlr-20190630.xml smlr-20190630.xsd smlr-20190630_cal.xml smlr-20190630_def.xml smlr-20190630_lab.xml smlr-20190630_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 52 0001144204-19-037447-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-19-037447-xbrl.zip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end